page image

Dysplasie

Referenties

  1. Butterworth CE Jr et al: Folate deficiency and cervical dysplasia; JAMA 267:528-533, 1992.
  2. Lindenbaum J et al: Oral contraceptive hormones, folate, metabolism, and the cervical epithelium; Am. J. Clin. Nutr. 28(4):346-353, 1975.
  3. VanEenwyk J et al: Folate, vitamin C, and cervical intraepithelial neoplasia; Cancer Epidemiol. Biomarkers Prev. 1(2):119-124, 1992.
  4. Whitehead N et al: Megaloblastic changes in the cervical epithelium: Association with oral contraceptive therapy and reversal with folic acid; JAMA 226:1421-1424, 1973.
  5. Piyathilake CJ et al: Folate is associated with the natural history of high-risk human papillomaviruses; Cancer Res. 64:8788-8793, 2004.
  6. Butterworth CE Jr et al: Improvement in cervical dysplasia associated with folic acid therapy in users of oral contraceptives; Am. J. Clin. Nutr. 35:73-82, 1982.
  7. Butterworth CE Jr et al: Oral folic acid supplementation for cervical dysplasia: a clinical intervention trial; Am. J. Obstet. Gynecol. 166(30):803-809, 1992.
  8. Childers JM et al: Chemoprevention of cervical cancer with folic acid: a phase III Southwest Oncology Group Intergroup study; Cancer Epidemiol. Biomarkers Prev. 4(2):155-159, 1995.
  9. Thomson ME, Pack ARC: Effects of extended systemic and topical folate supplementation on gingivitis of pregnancy; J. Clin. Periodontal 9(3):275-280, 1982.
  10. Palan P et al: Beta carotene levels in exfoliated cervicovaginal epithelial cells in cervical intraepithelial neoplasia and cervical cancer; Am. J. Obstet. Gynecol. 167:1899-1903, 1992.
  11. Giuliano AR et al: Antioxidant nutrients: associations with persistent human papillomavirus infection; Cancer Epidemiol. Biomark. Prev. 6:917-923, 1997.
  12. Sedjo R et al: Effect of plasma micronutrients on clearance of oncogenic human papillomavirus (HPV) infection (United States); Cancer Causes Control 14:319-326, 2003.
  13. Meyskens F (Clinical Cancer Center, U. of California, Irvine, CA): Prevention of cervical dysplasia. Abstract; Second Int. Conf. on Antioxidant Vitamins and Beta-carotene in Disease Prevention, Berlin, Germany, October 10-12, 1994.
  14. Mackerras D et al: Randomized double-blind trial of beta-carotene and vitamin C in women with minor cervical abnormalities; Br. J. Cancer 79(9-10):1448-1453, 1999.
  15. Keefe KA et al: A randomized, double blind, Phase III trial using oral beta-carotene supplementation for women with high-grade cervical intraepithelial neoplasia; Cancer Epidemiol. Biomarkers Prev. 10(10):1029-1035, 2001.
  16. Wylie-Rosett JA et al: Influence of vitamin A on cervical dysplasia and carcinoma in situ; Nutr Cancer 6(1):49-57, 1984.
  17. Volz J et al: Changes in the vitamin A status in dysplastic epithelium of the cervix; Zentralbl. Gynakol. 117(9):472-475, 1995.
  18. Meyskens FL Jr et al: Enhancement of regression of cervical intraepithelial neoplasia II (moderate dysplasia) with topically applied all-trans-retinoic acid: a randomized trial; J. Natl. Cancer Inst. 86(7):539-543, 1994.

Terug naar overzicht